Utilizing Machine Learning and Artificial Intelligence to Repurpose and Optimize Drugs Against the EGFR Cancer Causing Protein

A machine learning and AI algorithm that ranks 9,508 potential drug candidates to help find a new anticancer drug that can slow down the growth of cancer cells. The AI algorithm also generates new drug candidates with optimized drug-like properties like weight and solubility to ensure these potential drugs can be taken safely by mouth.